Management Recommendations for 86-Year-Old Female with Type 1.5 Diabetes
Primary Recommendation
Your current regimen requires immediate modification: the Metformin dose change is appropriate, but the Tresiba dose of 14 units is reasonable as a starting point, and the Novolog sliding scale should be replaced with a structured carbohydrate-counting approach with fixed meal doses to prevent both hypo- and hyperglycemia in this elderly patient. 1, 2, 3
Critical Age-Related Considerations
In patients over 65 years, preventing hypoglycemia takes absolute priority over tight glycemic control, as this population has increased risk of severe hypoglycemia due to reduced hypoglycemia awareness, potential cognitive impairment, and higher likelihood of renal/hepatic impairment. 1
- Set more relaxed glycemic targets for this 86-year-old patient: fasting glucose 100-140 mg/dL and HbA1c <8% (rather than <7%) to minimize hypoglycemia risk while preventing symptomatic hyperglycemia and dehydration. 1
- Avoid aggressive insulin titration that could lead to severe hypoglycemia, which carries greater morbidity/mortality risk than modest hyperglycemia in elderly patients. 1
Metformin Optimization
Your switch from Metformin ER 500mg twice daily to 750mg once daily is appropriate and may improve adherence, though the total daily dose is being reduced from 1000mg to 750mg. 1
Key Safety Monitoring for Metformin in Elderly Patients:
- Check eGFR immediately and at least annually (more frequently in elderly patients) - Metformin is contraindicated if eGFR <30 mL/min/1.73m² and initiation is not recommended if eGFR 30-45 mL/min/1.73m². 4
- Assess for lactic acidosis risk factors: At 86 years old, she has increased risk due to age alone; also evaluate for hepatic impairment, heart failure, and alcohol use. 4
- Monitor vitamin B12 levels every 2-3 years as Metformin interferes with B12 absorption, which can cause anemia. 4
- Hold Metformin 48 hours before any contrast imaging procedures and restart only after confirming stable renal function. 4
Basal Insulin (Tresiba) Management
The Tresiba 14 units once daily is a reasonable starting dose for a 138lb (62.7kg) patient, equating to approximately 0.22 units/kg/day, which falls within the conservative range appropriate for elderly patients. 2
Titration Strategy:
- Increase by only 2 units once weekly (not twice weekly as in younger patients) based on average fasting glucose over 3 days to minimize hypoglycemia risk. 2
- Target fasting glucose of 100-140 mg/dL (not <100 mg/dL) given her age and hypoglycemia risk. 1, 2
- If basal dose exceeds 0.5 units/kg/day (approximately 31 units) and HbA1c remains elevated, consider adding a GLP-1 receptor agonist rather than continuing to escalate insulin, as this reduces hypoglycemia risk. 2
- Monitor for duration of action: Some patients find glargine/degludec doesn't last 24 hours; if pre-dinner glucose rises significantly, consider splitting to twice-daily dosing (e.g., 7 units morning and 7 units evening). 2
Prandial Insulin (Novolog) - Critical Modification Needed
Replace the sliding scale approach with structured meal-based dosing, as sliding scales are reactive rather than proactive and lead to poor glycemic control. 3
Recommended Approach:
- Start with 4 units of Novolog before the largest meal (typically dinner), administered 5-10 minutes before eating. 3, 5
- Educate on carbohydrate counting: Match insulin to carbohydrate intake (typical starting ratio is 1 unit per 15g carbohydrate, but this must be individualized). 1, 3
- Add correction doses cautiously: Use a correction factor of 1 unit per 50 mg/dL above target (e.g., if target is 120 mg/dL and glucose is 170 mg/dL, add 1 unit to meal dose). 3
- Titrate by 1-2 units weekly based on 2-hour postprandial glucose readings (target <180 mg/dL). 3
- Never give rapid-acting insulin at bedtime to prevent nocturnal hypoglycemia. 3
Critical Safety Education:
- Hypoglycemia recognition and treatment: She must carry fast-acting carbohydrates (15g glucose tablets) at all times and know to treat glucose <70 mg/dL immediately. 5
- Always check insulin label before injection to avoid mix-ups between Tresiba and Novolog. 5
- Reduced warning signs: At 86, she may have reduced hypoglycemia awareness; family members should be educated on recognizing confusion, unusual behavior, or altered consciousness. 1
Continuous Glucose Monitoring (Libre 3+) Utilization
The Libre 3+ is invaluable for this elderly patient as it can detect hypoglycemia that might otherwise go unrecognized, particularly nocturnal episodes. 1
Optimal Use Strategy:
- Set alert thresholds conservatively: Low glucose alert at 80 mg/dL (not 70 mg/dL) and high glucose alert at 250 mg/dL to allow early intervention. 1
- Review CGM data weekly to identify patterns: if nocturnal hypoglycemia occurs, reduce evening Tresiba dose by 10-20%. 2
- Fingerstick confirmation: When CGM shows glucose <70 mg/dL or >250 mg/dL, confirm with fingerstick before making treatment decisions, as CGM can lag during rapid changes. 1
- Family involvement: Ensure family members can access CGM data remotely to monitor for concerning patterns. 1
Exercise and Activity Modifications
Physical activity improves glucose control but requires insulin adjustments to prevent hypoglycemia. 1
- Reduce Novolog dose by 25-50% before planned exercise or consume 15-30g extra carbohydrates. 1
- Avoid injecting Tresiba into legs before exercise as absorption accelerates during activity. 1
- Check glucose before, during (if >60 minutes), and after exercise; treat if <100 mg/dL before starting. 1
- Recommend 30 minutes daily of moderate activity (brisk walking) to improve insulin sensitivity and cardiovascular health. 1
Monitoring Schedule
Establish a structured monitoring plan to ensure safety while avoiding excessive testing burden:
- Fasting glucose daily (before breakfast) to guide Tresiba titration. 2
- Pre-meal glucose before largest meal to guide Novolog dosing. 3
- 2-hour postprandial glucose 2-3 times weekly to assess Novolog adequacy. 3
- HbA1c every 3 months until stable, then every 6 months (target <8%). 1
- eGFR and vitamin B12 annually due to Metformin use. 4
- Review CGM data weekly for patterns requiring intervention. 1
Special Situations Requiring Immediate Insulin Adjustment
Educate patient and family on scenarios requiring medication changes:
- Illness/infection: May need to increase insulin by 10-20% but maintain close monitoring; never stop insulin completely even if not eating. 1
- Reduced oral intake: If eating <50% of usual intake, reduce Novolog by 50% but continue Tresiba at reduced dose (never stop completely in type 1.5 diabetes). 1
- Surgery/procedures: Hold Metformin 48 hours before; continue basal insulin at 75% of usual dose; hold Novolog until eating resumes. 4
- Hospitalization: Simplified regimen may be needed; basal insulin should continue but prandial insulin adjusted based on intake. 1
Common Pitfalls to Avoid
- Do not rely solely on sliding scale insulin - this reactive approach leads to poor control and increased hypoglycemia risk. 3
- Do not aggressively titrate to HbA1c <7% in this elderly patient - the risk of severe hypoglycemia outweighs benefits. 1
- Do not continue sulfonylureas if added - these significantly increase hypoglycemia risk when combined with insulin. 6
- Do not ignore nocturnal hypoglycemia - review CGM data specifically for overnight patterns and reduce evening insulin if glucose drops below 80 mg/dL. 7, 8
- Do not assume she has adequate hypoglycemia awareness - elderly patients often have blunted symptoms; rely on CGM alerts. 1
When to Consider Regimen Simplification
If hypoglycemia becomes problematic or patient/family cannot manage complexity, consider these alternatives:
- Switch to twice-daily premixed insulin (70/30 or similar) instead of basal-bolus regimen for simplicity. 1
- Add GLP-1 receptor agonist and reduce insulin doses to minimize hypoglycemia while maintaining control. 2
- Discontinue Metformin if eGFR declines or gastrointestinal side effects occur. 4
- Focus on preventing symptomatic hyperglycemia (glucose >250 mg/dL) rather than achieving tight control if quality of life is impaired. 1